Trials / Conditions / Myopic Choroidal Neovascularisation
Myopic Choroidal Neovascularisation
8 registered clinical trials studyying Myopic Choroidal Neovascularisation — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Effectiveness of Intravitreal Injection of Aflibercept 8 mg in Resistant Diabetic Macular Edema, Retinal Vein NCT06879301 | Tanta University | EARLY_Phase 1 |
| Not Yet Recruiting | The Treatment Burden of Myopic Choroidal Neovascularization NCT07009574 | Policlinico Gaspare Rodolico - San Marco Catania | — |
| Not Yet Recruiting | OCTA Changes in Choroidal Neovascularization in High Myopia NCT06357559 | Sohag University | — |
| Completed | VISUPRIME® Eye Drops NCT05677685 | VISUfarma SpA | N/A |
| Suspended | CM082 in Patients With Myopic Choroidal Neovascularization (CNV) NCT04222842 | AnewPharma | Phase 1 |
| Completed | Intravitreal Conbercept Injection in Patients With Myopic Choroidal Neovascularization NCT03971162 | Zhongshan Ophthalmic Center, Sun Yat-sen University | N/A |
| Unknown | Effect of Corona Virus on Intravitreal Injections NCT05494775 | Benha University | N/A |
| Unknown | Real Life Study in Myopic Neovascularization NCT03797547 | Poitiers University Hospital | — |